Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

      Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules

      Medical Dialogues Bureau10 April 2020 12:01 PM IST
      Butalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension headache.
      Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

      Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol

      Medical Dialogues Bureau10 April 2020 10:00 AM IST
      Mumbai: Cipla Limited has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate...
      US pharmacies authorized to test for COVID-19

      US pharmacies authorized to test for COVID-19

      Medical Dialogues Bureau10 April 2020 9:00 AM IST
      Washington: The US authorized pharmacies on Wednesday to carry out tests for the coronavirus, including newly developed antibody tests that detect...
      No need to panic over availability of PPE: Health ministry

      No need to panic over availability of PPE: Health ministry

      Medical Dialogues Bureau10 April 2020 9:00 AM IST
      New Delhi: The Union health ministry on Thursday said there is no need to panic over the availability of COVID-19 personal protective equipment (PPE),...
      Aurobindo Pharma faces CA Suit in US for concealing facts

      Aurobindo Pharma faces CA Suit in US for concealing facts

      Medical Dialogues Bureau9 April 2020 1:36 PM IST
      Hyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court...
      Zydus gets USFDA final approval for Imatinib Mesylate Tablets

      Zydus gets USFDA final approval for Imatinib Mesylate Tablets

      Medical Dialogues Bureau9 April 2020 1:01 PM IST
      Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Imatinib Mesylate Tablets, 100 mg and 400 mg. (US RLD: Gleevec®...
      With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

      With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India

      Medical Dialogues Bureau9 April 2020 12:30 PM IST
      New Delhi: Drug firm Roche India on Wednesday said it has launched immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative...
      Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

      Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT

      Medical Dialogues Bureau9 April 2020 10:00 AM IST
      New York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
      Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJP

      Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJP

      Medical Dialogues Bureau9 April 2020 9:00 AM IST
      Delhi: Pharmacists, popularly known as "Swasth Ke Sipahi", of Pradhan Mantri Jan Aushadhi Kendra, are delivering essential services and medicines at...
      Merck KEYTRUDA gets USFDA priority review for its Second Application

      Merck KEYTRUDA gets USFDA priority review for its Second Application

      Medical Dialogues Bureau9 April 2020 9:00 AM IST
      Kenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted and...
      Jubilant Life Sciences Karnataka plant shut on coronavirus scare

      Jubilant Life Sciences Karnataka plant shut on coronavirus scare

      Medical Dialogues Bureau8 April 2020 2:15 PM IST
      Mysuru: The drug-making plant of pharma major Jubilant Life Sciences at Nanjangud near here has been shut down after it was suspected to have been...
      Zydus gets USFDA final approval for Perphenazine Tablets USP

      Zydus gets USFDA final approval for Perphenazine Tablets USP

      Medical Dialogues Bureau8 April 2020 12:56 PM IST
      Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg. (US RLD: Trilafon®...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok